IMNN-001

GEN-1 · Imunon

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IMNN-001, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) [Phase 1, Phase 2]